Which Cancers Are Treated with Checkpoint Inhibitors?
Checkpoint inhibitors have been approved for a variety of cancers including [melanoma](), [non-small cell lung cancer](), [kidney cancer](), [bladder cancer](), and [Hodgkin lymphoma](). They are also being tested in clinical trials for other types of cancer, including [breast cancer]() and [prostate cancer](). The effectiveness of these inhibitors can vary depending on the type of cancer and the specific checkpoint targeted.
